Targeted Nanomedicines Group
Targeted Nanomedicines Group focuses on developing organ-specific immunomodulatory nanoparticles to treat inflammatory diseases.
It is the University’s expectation that only those who are well and not presenting with COVID-19 symptoms attend a Monash campus or location. View our latest updates.
Targeted Nanomedicines Group focuses on developing organ-specific immunomodulatory nanoparticles to treat inflammatory diseases.
